Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

Neuro-Oncology

Volumn 7, Issue 4, 2005, Pages 436-451

  Abounader, Roger ^a   Laterra, John ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood vessel formation; c Met; Glioma

Indexed keywords

ANGIOSTATIN; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; NK 4; PHA 665752; PROTEIN TYROSINE KINASE INHIBITOR; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SMALL NUCLEAR RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BRAIN TUMOR; CANCER GRADING; CANCER INHIBITION; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COMPETITIVE INHIBITION; CORRELATION ANALYSIS; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GENE DELIVERY SYSTEM; GLIOMA; HUMAN; IN VIVO STUDY; LIGAND BINDING; NONHUMAN; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT; VASCULAR ENDOTHELIUM;

ANIMALS; BRAIN NEOPLASMS; HEPATOCYTE GROWTH FACTOR; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION;

EID: 27644543354     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1152851705000050     Document Type: Review

References (87)

1. Abounader, R., Ranganathan, S., Lal, B., Fielding, K., Book, A., Dietz, H., Burger, P., and Laterra, J. (1999) Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. J. Natl. Cancer Inst. 91, 1548-1556.
2. Abounader, R., Lal, B., Luddy, C., Koe, G., Davidson, B., Rosen, E.M., and Laterra, J. (2002) In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis. FASEB J. 16, 108-110.
3. Abounader, R., Reznik, T., Kuchner, E., Kwon, S., Saldanha, U., Dasgupta, N., Russel, J., Eberhart, C., and Laterra, J. (2004a) Characterization of the scatter factor/hepatocyte growth factor: c-Met pathway in human medulloblastoma malignancy. Am. Assoc. Cancer Res. Available at http://aacr04.agora.com/planner (abstract 4348).
4. Abounader, R., Montgomery, R., Dietz, H., and Laterra, J. (2004b) Design and expression of chimeric U1/ribozyme transgenes. Methods Mol. Biol. 252, 209-219.
5. Alexandrakis, M.G., Passam, F.J., Ganotakis, E., Dafnis, E., Dambaki, C., Konsolas, J., Kyriakou, D.S., and Stathopoulos, E. (2004) Bone marrow microvascular density and angiogenic growth factors in multiple myeloma. Clin. Chem. Lab. Med. 42, 1122-1126.
6. Arrieta, O., Garcia, E., Guevara, P., Garcia-Navarrete, R., Ondarza, R., Rembao, D., and Sotelo, J. (2002) Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma. Cancer 94, 3210-3218.
7. Beilmann, M., Birk, G., and Lenter, M.C. (2004) Human primary co-culture angiogenesis assay reveals additive stimulation and different angiogenic properties of VEGF and HGF. Cytokine 26, 178-185.
8. Birchmeier, C., Birchmeier, W., Gherardi, E., and Vande Woude, G.F. (2003) Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915-925.
9. Birchmeier, C., and Gherardi, E. (1998) Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 8, 404-410.
10. Boccaccio, C., Ando, M., Tamagnone, L., Bardelli, A., Michieli, P., Battistini, C., and Comoglio, P.M. (1998) Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391, 285-288.
11. Bottaro, D.P., Rubin, J.S., Faletto, D.L., Chan, A.M., Kmiecik, T.E., Vande Woude, G.F., and Aaronson, S.A. (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251, 802-804.
12. Bowers, D.C., Fan, S., Walter, K.A., Abounader, R., Williams, J.A., Rosen, E.M., and Laterra, J. (2000) Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. Cancer Res. 60, 4277-4283.
13. Brockmann, M.A., Ulbricht, U., Gruner, K., Fillbrandt, R., Westphal, M., and Lamszus, K. (2003a) Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor-associated growth factors. Neurosurgery 52, 1391-1399.
14. Brockmann, M.A., Papadimitriou, A., Brandt, M., Fillbrandt, R., Westphal, M., and Lamszus, K. (2003b) Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4. Clin. Cancer Res. 9, 4578-4585.
15. Bussolino, F., Di Renzo, M.F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A., and Comoglio, P.M. (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119, 629-641.
16. Cao, B., Su, Y., Oskarsson, M., Zhao, P., Kort, E.J., Fisher, R.J., Wang, L.M., and Vande Woude, G.F. (2001) Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc. Natl. Acad. Sci. USA 98, 7443-7448.
17. Christensen, J.G., Schreck, R., Burrows, J., Kuruganti, P., Chan, E., Le, P., Chen, J., Wang, X., Ruslim, L., Blake, R., Lipson, K.E., Ramphal, J., Do, S., Cui, J.J., Cherrington, J.M., and Mendel, D.B. (2003) A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res. 63, 7345-7355.
18. Cooper, C.S., Park, M., Blair, D.G., Tainsky, M.A., Huebner, K., Croce, C.M., and Vande Woude, G.F. (1984) Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311, 29-33.
19. Ding, S., Merkulova-Rainon, T., Han, Z.C., and Tobelem, G. (2003) HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. Blood 101, 4816-4822.
20. Furlong, R.A., Takehara, T., Taylor, W.G., Nakamura, T., and Rubin, J.S. (1991) Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable. J. Cell Sci. 100 (Pt 1), 173-177.
21. Gerritsen, M.E., Tomlinson, J.E., Zlot, C., Ziman, M., and Hwang, S. (2003) Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells. Br. J. Pharmacol. 140, 595-610.
22. Gherardi, E., Youles, M.E., Miguel, R.N., Blundell, T.L., Iamele, L., Gough, J., Bandyopadhyay, A., Hartmann, G., and Butler, P.J. (2003) Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. USA 100, 12039-12044.
23. Grant, D.S., Kleinman, H.K., Goldberg, I.D., Bhargava, M.M., Nickoloff, B.J., Kinsella, J.L., Polverini, P., and Rosen, E.M. (1993) Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. USA 90, 1937-1941.
24. Grant, D.S., Rose, R.W., Kinsella, J.K., and Kibbey, M.C. (1995) Angiogenesis as a component of epithelial-mesenchymal interactions. EXS 74, 235-248.
25. Hayashi, S., Morishita, R., Higaki, J., Aoki, M., Moriguchi, A., Kida, I., Yoshiki, S., Matsumoto, K., Nakamura, T., Kaneda, Y., and Ogihara, T. (1996) Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. Biochem. Biophys. Res. Commun. 220, 539-545.
26. Hecht, M., Papoutsi, M., Tran, H.D., Wilting, J., and Schweigerer, L. (2004) Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas. Cancer Res. 64, 6109-6118.
27. Jeffers, M., Schmidt, L., Nakaigawa, N., Webb, C.P., Weirich, G., Kishida, T., Zbar, B., and Vande Woude, G.F. (1997) Activating mutations for the met tyrosine kinase receptor in human cancer. Proc. Natl. Acad. Sci. USA 94, 11445-11450.
28. Jiang, W.G., Hiscox, S.E., Parr, C., Martin, T.A., Matsumoto, K., Nakamura, T., and Mansel, R.E. (1999) Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Clin. Cancer Res. 5, 3695-3703.
29. Koochekpour, S., Jeffers, M., Rulong, S., Taylor, G., Klineberg, E., Hudson, E.A., Resau, J.H., and Vande Woude, G.F. (1997) Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res. 57, 5391-5398.
30. Kuba, K., Matsumoto, K., Date, K., Shimura, H., Tanaka, M., and Nakamura, T. (2000) HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res. 60, 6737-6743.
31. Kuhnen, C., Muehlberger, T., Honsel, M., Tolnay, E., Steinau, H.U., and Muller, K.M. (2003) Impact of c-Met expression on angiogenesis in soft tissue sarcomas: Correlation to microvessel-density. J. Cancer Res. Clin. Oncol. 129, 415-422.
32. Kuniyasu, H., Yasui, W., Kitadai, Y., Yokozaki, H., Ito, H., and Tahara, E. (1992) Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem. Biophys. Res. Commun. 189, 227-232.
33. Kunkel, P., Müller, S., Schirmacher, P., Stavrou, D., Fillbrandt, R., Westphal, M., and Lamszus, K. (2001) Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas. Neuro-Oncology 3, 82-88.
34. Lafleur, M.A., Handsley, M.M., Knauper, V., Murphy, G., and Edwards, D.R. (2002) Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J. Cell Sci. 115, 3427-3438.
35. Lal, B., Xia, S., Abounader, R., and Laterra, J. (2005) Targeting the c-Met pathway potentiates glioblastoma responses to α-radiation. Clin. Cancer Res. 11, 4479-4486
36. Lamszus, K., Jin, L., Fuchs, A., Shi, E., Chowdhury, S., Yao, Y., Polverini, P.J., Laterra, J., Goldberg, I.D., and Rosen, E.M. (1997) Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab. Invest. 76, 339-353.
37. Lamszus, K., Schmidt, N.O., Jin, L., Laterra, J., Zagzag, D., Way, D., Witte, M., Weinand, M., Goldberg, I.D., Westphal, M., and Rosen, E.M. (1998) Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int. J. Cancer 75, 19-28.
38. Lamszus, K., Laterra, J., Westphal, M., and Rosen, E.M. (1999) Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int. J. Dev. Neurosci. 17, 517-530.
39. Laterra, J., Nam, M., Rosen, E., Rao, J.S., Lamszus, K., Goldberg, I.D., and Johnston, P. (1997a) Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Lab. Invest. 76, 565-577.
40. Laterra, J., Rosen, E., Nam, M., Ranganathan, S., Fielding, K., and Johnston, P. (1997b) Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth. Biochem. Biophys. Res. Commun. 235, 743-747.
41. Ma, H., Calderon, T.M., Fallon, J.T., and Berman, J.W. (2002) Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques. Atherosclerosis 164, 79-87.
42. MacDonald, T.J., Brown, K.M., LaFleur, B., Peterson, K., Lawlor, C., Chen, Y., Packer, R.J., Cogen, P., and Stephan, D.A. (2001) Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat. Genet. 29, 143-152.
43. Madden, S.L., Cook, B.P., Nacht, M., Weber, W.D., Callahan, M.R., Jiang, Y., Dufault, M.R., Zhang, X., Zhang, W., Walter-Yohrling, J., Rouleau, C., Akmaev, V.R., Wang, C.J., Cao, X., St. Martin, T.B., Roberts, B.L., Teicher, B.A., Klinger, K.W., Stan, R.-V., Lucey, B., Carson-Walter, E.B., Laterra, J., and Walter, K.A. (2004) Vascular gene expression in non-neoplastic and malignant brain. Am. J. Pathol. 165, 601-608.
44. Martin, T.A., Harding, K.G., and Jiang, W.G. (1999) Regulation of angiogenesis and endothelial cell motility by matrix-bound fibroblasts. Angiogenesis 3, 69-76.
45. Martin, T.A., Mansel, R., and Jiang, W.G. (2001) Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells. Clin. Cancer Res. 7, 734-737.
46. Martinez-Rumayor, A., Arrieta, O., Guevara, P., Escobar, E., Rembao, D., Salina, C., and Sotelo, J. (2004) Coexpression of hepatocyte growth factor/scatter factor (HGF/SF) and its receptor cMET predict recurrence of meningiomas. Cancer Lett. 213, 117-124.
47. Matsumoto, K., and Nakamura, T. (2003) NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics. Cancer Sci. 94, 321-327.
48. Michalopoulos, G.K., and DeFrances, M.C. (1997) Liver regeneration. Science 276, 60-66.
49. Michieli, P., Mazzone, M., Basilico, C., Cavassa, S., Sottile, A., Naldini, L., and Comoglio, P.M. (2004) Targeting the tumor and its microenvironment by a dual-function decoy Met receptor. Cancer Cell 6, 61-73.
50. Miyazawa, K., Shimomura, T., Kitamura, A., Kondo, J., Morimoto, Y., and Kitamura, N. (1993) Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J. Biol. Chem. 268, 10024-10028.
51. Moriyama, T., Kataoka, H., Kawano, Y., Yokogami, K., Nakano, S., Goya, T., Uchino, H., Koono, M., and Wakisaka, S. (1998a) Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans. Cancer Lett. 124, 149-155.
52. Moriyama, T., Kataoka, H., Hamasuna, R., Yokogami, K., Uehara, H., Kawano, H., Goya, T., Tsubouchi, H., Koono, M., and Wakisaka, S. (1998b) Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Biochem. Biophys. Res. Commun. 249, 73-77.
53. Muleris, M., Almeida, A., Dutrillaux, A.M., Pruchon, E., Vega, F., Delattre, J.-Y., Poisson, M., Malfoy, B., and Dutrillaux, B. (1994) Oncogene amplification in human gliomas: A molecular cytogenetic analysis. Oncogene 9, 2717-2722.
54. Nakagami, H., Morishita, R., Yamamoto, K., Taniyama, Y., Aoki, M., Matsumoto, K., Nakamura, T., Kaneda, Y., Horiuchi, M., and Ogihara, T. (2001) Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Hypertension 37, 581-586.
55. Nakamura, T., Nawa, K., and Ichihara, A. (1984) Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122, 1450-1459.
56. Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K., and Shimizu, S. (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342, 440-443.
57. Nakamura, Y., Morishita, R., Higaki, J., Kida, I., Aoki, M., Moriguchi, A., Yamada, K., Hayashi, S.I., Yo, Y., Matsumoto, K., Nakamura, T., and Ogihara T. (1995) Expression of local hepatocyte growth factor system in vascular tissues. Biochem. Biophys. Res. Commun. 215, 483-488.
58. Oh, I.S., So, S.S., Jahng, K.Y., and Kim, H.G. (2002) Hepatocyte growth factor upregulates thymosin beta4 in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 296, 401-405.
59. O'Reilly, M.S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W.S., Cao, Y., Sage, E.H., and Folkman, J. (1994) Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
60. Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., dalla Zonca, P., Giordano, S., Graziani, A., Panayoyou, G., and Comoglio, P.M. (1994) A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77, 261-271.
61. Purdie, K.J., Whitley, G.S., Johnstone, A.P., and Cartwright, J.E. (2002) Hepatocyte growth factor-induced endothelial cell motility is mediated by the upregulation of inducible nitric oxide synthase expression. Cardiovasc. Res. 54, 659-668.
62. Reisinger, K., Kaufmann, R., and Gille, J. (2003) Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription. J. Cell Sci. 116, 225-238.
63. Rosen, E.M., Lamszus, K., Laterra, J., and Poverini, P.J. (1999) Scatter factor as a tumor angiogenesis factor. In: Rubanyi, G.M. (Ed.), Angiogenesis in Health and Disease: Basic Mechanisms and Clinical Applications. New York: Marcel Dekker, Inc., pp. 145-156.
64. Rosen, E.M., Laterra, J., Joseph, A., Jin, L., Fuchs, A., Way, D., Witte, M., Weinand, M., and Goldberg, I.D. (1996) Scatter factor expression and regulation in human glial tumors. Intl. J. Cancer 67, 248-255.
65. Rosen, E.M., Meromsky, L., Setter, E., Vinter, D.W., and Goldberg, I.D. (1990) Smooth muscle-derived factor stimulates mobility of human tumor cells. Invasion Metastasis 10, 49-64.
66. Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., and Birchmeier, C. (1995) Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373, 699-702.
67. Schmidt, L., Duh, F.M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S.W., Zhuang, Z., Lubensky, I., Dean, M., Allikmets, R., Chidambaram, A., Bergerheim, U.R., Feltis, J.T., Casadevall, C., Zamarron, A., Bernues, M., Richard, S., Lips, C.J.M., Walther, M.M., Tsui, L.-C., Geil, L., Orcutt, M.L., Stackhouse, T., Lipan, J., Slife, L., Brauch, H., Decker, J., Niehans, G., Hughson, M.D., Moch, H., Storkel, S., Lerman, M.I., Linehan, W.M., and Zbar, B. (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 16, 68-73 (letter).
68. Schmidt, N.O., Westphal, M., Hagel, C., Ergun, S., Stavrou, D., Rosen, E.M., and Lamszus, K. (1999) Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int. J. Cancer 84, 10-18.
69. Seki, T., Hagiya, M., Shimonishi, M., Nakamura, T., and Shimizu, S. (1991) Organization of the human hepatocyte growth factor-encoding gene. Gene 102, 213-219.
70. Sengupta, S., Gherardi, E., Sellers, L.A., Wood, J.M., Sasisekharan, R., and Fan, T.P. (2003) Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 23, 69-75.
71. Skoldenberg, E.G., Christiansson, J., Sandstedt, B., Larsson, A., Lackgren, G., and Christofferson, R. (2001) Angiogenesis and angiogenic growth factors in Wilms tumor. J. Urol. 165, 2274-2279.
72. Sonnenberg, E., Meyer, D., Weidner, K.M., and Birchmeier, C. (1993) Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123, 223-235.
73. St. Croix, B., Rago, C., Velculescu, V., Traverso, G., Romans, K.E., Montgomery, E., Lal, A., Riggins, G.J., Lengauer, C., Vogelstein, B., and Kinzler, K.W. (2000) Genes expressed in human tumor endothelium. Science 289, 1197-1202.
74. Stoker, M., and Perryman, M. (1985) An epithelial scatter factor released by embryo fibroblasts. J. Cell Sci. 77, 209-223.
75. Tacchini, L., Matteucci, E., De Ponti, C., and Desiderio, M.A. (2003) Hepatocyte growth factor signaling regulates transactivation of genes belonging to the plasminogen activation system via hypoxia inducible factor-1. Exp. Cell Res. 290, 391-401.
76. Tomita, N., Morishita, R., Taniyama, Y., Koike, H., Aoki, M., Shimizu, H., Matsumoto, K., Nakamura, T., Kaneda, Y., and Ogihara, T. (2003) Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1. Circulation 107, 1411-1417.
77. Uehara, Y., Minowa, O., Mori, C., Shiota, K., Kuno, J., Noda, T., and Kitamura, N. (1995) Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373, 702-705.
78. Van Belle, E., Witzenbichler, B., Chen, D., Silver, M., Chang, L., Schwall, R., and Isner, J.M. (1998) Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: The case for paracrine amplification of angiogenesis. Circulation 97, 381-390.
79. Wagatsuma, S., Konno, R., Sato, S., and Yajima, A. (1998) Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer 82, 520-530.
80. Walter, K.A., Hossain, M.A., Luddy, C., Goel, N., Reznick, T.E., and Laterra, J. (2002) Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent, and independent of p27 suppression, cdk2 activation, or E2F1-dependent transcription. Mol. Cell. Biol. 22, 2703-2715.
81. Wang, H., and Keiser, J.A. (2000) Hepatocyte growth factor enhances MMP activity in human endothelial cells. Biochem. Biophys. Res. Commun. 272, 900-905.
82. Wang, X., Zhou, Y., Kim, H.P., Song, R., Zarnegar, R., Ryter, S.W., and Choi, A.M. (2004) Hepatocyte growth factor protects against hypoxia/reoxygenation-induced apoptosis in endothelial cells. J. Biol. Chem. 279, 5237-5243.
83. Weidner, K.M., Arakaki, N., Hartmann, G., Vandekereckhove, J., Weingart, S., Rieder, H., Fonatsch, C., Tsubouchi, H., Hishida, T., and Daikuhara, Y. (1991) Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc. Natl. Acad. Sci. USA 88, 7001-7005.
84. Wojta, J., Kaun, C., Breuss, J.M., Koshelnick, Y., Beckmann, R., Hattey, E., Mildner, M., Weninger, W., Nakamura, T., Tschachler, E., and Binder, B.R. (1999) Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. Lab. Invest. 79, 427-438.
85. Xin, X., Yang, S., Ingle, G., Zlot, C., Rangell, L., Kowalski, J., Schwall, R., Ferrara, N., and Gerritsen, M.E. (2001) Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am. J. Pathol. 158, 1111-1120.
86. Yamamoto, K., Morishita, R., Hayashi, S., Matsushita, H., Nakagami, H., Moriguchi, A., Matsumoto, K., Nakamura, T., Kaneda, Y., and Ogihara, T. (2001) Contribution of Bcl-2, but not Bcl-xL and Bax, to anti-apoptotic actions of hepatocyte growth factor in hypoxia-conditioned human endothelial cells. Hypertension 37, 1341-1348.
87. Zhang, Y.-W., Su, Y., Volpert, O.V., and Vande Woude, G.F. (2003) Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc. Natl. Acad. Sci. USA 100, 12718-12723.